Cidara Therapeutics, Inc. financial data

Symbol
CDTX on Nasdaq
Location
6310 Nancy Ridge Drive, Suite 101, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 607 % +204%
Quick Ratio 8.19 %
Debt-to-equity 18.8 % -82.3%
Return On Equity -60.2 % +72.5%
Return On Assets -50.6 % +52.3%
Operating Margin -63.9K % -3179%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.4M shares +346%
Common Stock, Shares, Outstanding 29.3M shares +316%
Entity Public Float 53.3M USD -46.8%
Common Stock, Value, Issued 3K USD +200%
Weighted Average Number of Shares Outstanding, Basic 26.9M shares +312%
Weighted Average Number of Shares Outstanding, Diluted 26.9M shares +312%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 2.83M USD
Research and Development Expense 132M USD +453%
General and Administrative Expense 13.6M USD -26.5%
Operating Income (Loss) -195M USD -39.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.5M USD -303%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -185M USD -53%
Earnings Per Share, Basic -8 USD/shares +66.9%
Earnings Per Share, Diluted -8 USD/shares +66.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 294M USD +131%
Accounts Receivable, after Allowance for Credit Loss, Current 1.86M USD +9.54%
Inventory, Net 7.27M USD
Assets, Current 443M USD +182%
Property, Plant and Equipment, Net 293K USD -47.8%
Operating Lease, Right-of-Use Asset 1.8M USD -40.9%
Other Assets, Noncurrent 23.6M USD +1799%
Assets 519M USD +220%
Accounts Payable, Current 4.35M USD +46.6%
Employee-related Liabilities, Current 3.51M USD -28.9%
Accrued Liabilities, Current 71.3M USD +733%
Liabilities, Current 95.8M USD +116%
Operating Lease, Liability, Noncurrent 424K USD -78.6%
Liabilities 96.3M USD +106%
Accumulated Other Comprehensive Income (Loss), Net of Tax -107K USD
Retained Earnings (Accumulated Deficit) -744M USD -33.1%
Stockholders' Equity Attributable to Parent 422M USD +265%
Liabilities and Equity 519M USD +220%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22M USD -230%
Net Cash Provided by (Used in) Financing Activities 77K USD
Net Cash Provided by (Used in) Investing Activities 185K USD
Common Stock, Shares Authorized 100M shares +100%
Common Stock, Shares, Issued 29.3M shares +316%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -21.7M USD -221%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 300M USD +135%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 121M USD +45.5%
Deferred Tax Assets, Gross 122M USD +43.9%
Operating Lease, Liability 1.98M USD -40%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -185M USD -53.1%
Lessee, Operating Lease, Liability, to be Paid 2.15M USD -43.4%
Property, Plant and Equipment, Gross 3.87M USD +3.15%
Operating Lease, Liability, Current 1.56M USD +18%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.73M USD +3.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.73M USD +4.03%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 163K USD -66.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.73M USD
Deferred Tax Assets, Operating Loss Carryforwards 46.7M USD +31.6%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 12.9M USD +12%
Operating Lease, Payments 400K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 782K USD -47.9%
Share-based Payment Arrangement, Expense 9.53M USD +209%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%